What causes “brain fog” and difficulty focusing?
Mental slowing, forgetfulness, or difficulty focusing are not attributable to a single cause. Sleep apnea, insufficient sleep, depression/anxiety, intense stress, B12-folate-iron deficiency, thyroid disease, glucose-insulin imbalance, medications, hormonal changes, and neurological diseases can lead to similar complaints.
Which components may be evaluated?
Citicoline is associated with cell membrane phospholipids and cholinergic transmission and has been studied in humans in the areas of memory and cognitive impairment. B12 and folate are important for neurological function in cases of true deficiency. B1, B6, and other B vitamins play a role in the nervous system and energy metabolism. Magnesium is associated with neuromuscular and synaptic processes. The clinical rationale for each component is evaluated separately.
Citicoline and cognitive research
A randomized study in healthy older adults reported improvements in certain measures of episodic memory with oral citicoline. Meta-analyses evaluating studies of mild cognitive impairment and dementia also show positive signals; because study quality and populations are heterogeneous, individual response and appropriate patient selection are important.
A broader framework than IV infusions in cognitive aging
The WHO’s 2026 dementia risk reduction guideline addresses physical activity, tobacco cessation, management of cardiometabolic risks, cognitive engagement, hearing, and other modifiable factors as parts of a multidomain approach. Therefore, a cognitive health plan should be based not solely on a nootropic component but on sleep, movement, vascular-metabolic health, and social-cognitive activity.
How is the choice between oral and IV use made?
For citicoline and many micronutrients, a substantial portion of the human data comes from oral or various parenteral routes. When the IV route is considered, the preparation’s suitability for injection, pharmaceutical form, compatibility, and clinical use data are evaluated separately. The goal is not to choose a “stronger” route but to determine the most appropriate and safe route for the individual.
Evaluation and measurable goals
The onset of the complaint, daily functioning, sleep quality, stress, medications, blood pressure, and metabolic status are examined. When necessary, a complete blood count, ferritin, B12, folate, thyroid, glucose/HbA1c, and other selected tests are evaluated. If the cognitive complaint is pronounced, standardized screening tests or a neurological evaluation may be planned.
Safety
Depending on the ingredients, blood pressure, sleep, glucose, heart rhythm, or drug interactions may be affected. A history of seizures, pregnancy/breastfeeding, bipolar disorder, serious neurological disease, and the use of multiple psychiatric medications require special evaluation. Sterility and infusion safety are also monitored during intravenous administration.
Our approach at our Bodrum clinic
For complaints of “brain fog” or difficulty focusing, we first evaluate sleep, metabolic health, stress, B12-folate-iron, thyroid function, and medications being used. When necessary, we consider functional evaluation and training options such as QEEG/neurofeedback in a separate clinical context. If IV support is being considered, the ingredients are personalized according to the measurable cognitive goal and follow-up plan.
Frequently asked questions
Can a nootropic IV infusion improve memory?
Some components, such as citicoline, have shown positive cognitive outcomes in selected human studies. The effect may vary depending on the individual’s baseline status and the cause of the complaint; monitoring the contribution of a multicomponent IV infusion using measurable goals is more valuable.
Which tests are performed for brain fog?
There is no single “brain fog test.” Sleep, B12-folate-iron, thyroid function, glucose balance, medications, and neurological status are evaluated according to the medical history.
Related content
You can explore the pages on Citicoline, Cognitive aging and brain health, Neurofeedback, Sleep and healthy aging, B complex and B12, and IV and infusion treatments.
References
WHO 2026 guideline on risk reduction of cognitive decline and dementia; randomized studies and systematic reviews of citicoline; professional resources on B12 and micronutrients.
Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: 10 September 2026
